Iressa 250 mg Tablet
$50,16
$42,73
Iressa 250 mg tablet is an innovative treatment specifically designed for adults diagnosed with non-small cell lung cancer (NSCLC) that has metastasized to other regions of the body, particularly in patients exhibiting mutations in the EGFR gene and who have not previously undergone cancer therapy. This targeted therapy works by inhibiting the activity of the abnormal EGFR protein, which plays a crucial role in the growth and spread of cancer cells, thus helping to slow down disease progression and improve survival outcomes. It's important to note that Iressa is not recommended for use in pediatric patients due to insufficient data regarding its safety and efficacy in children and adolescents. Patients should be aware of potential side effects, which may include skin rashes, diarrhea, and liver function abnormalities, necessitating regular monitoring by healthcare professionals. Before starting treatment with Iressa, discussing any existing medical conditions and medications with a healthcare provider is essential to avoid harmful interactions. By providing a tailored approach to NSCLC management, Iressa 250 mg helps enhance treatment options for eligible patients, making it a vital component in the oncology landscape. Always consult your doctor for personalized advice and to ensure this medication aligns with your overall treatment plan.
數量
Active Pharmaceutical Ingredient
Uses
• Iressa 250 mg tablet is primarily indicated for the treatment of non-small cell lung cancer (NSCLC). This medication targets specific mutations in cancer cells, helping to inhibit their growth and spread. By focusing on the molecular characteristics of the tumor, Iressa 250 mg tablet can provide a more tailored approach to cancer therapy. Patients with advanced stages of NSCLC may find this treatment particularly beneficial.
• The efficacy of Iressa 250 mg tablet is often observed in patients who have previously undergone chemotherapy or radiation. It can be used as a second-line treatment option for those whose cancer has progressed despite other therapies. By blocking certain signals that promote cancer cell proliferation, Iressa 250 mg tablet helps to slow down the disease's advancement. This mechanism can lead to improved quality of life for patients.
• Iressa 250 mg tablet is also utilized in specific populations of NSCLC patients with identified EGFR mutations. These mutations are commonly found in non-small cell lung cancer and are crucial for determining the most effective treatment strategy. Using Iressa 250 mg tablet in these cases can lead to better response rates and may result in extended survival for eligible patients. Testing for these mutations is essential to optimize treatment outcomes.
• In addition to its primary use, Iressa 250 mg tablet may be part of a comprehensive treatment plan that includes regular monitoring and supportive care. Healthcare providers often recommend this medication to help manage the disease while minimizing side effects associated with traditional chemotherapy. The goal is to enhance patient comfort and maintain functionality during treatment. Iressa 250 mg tablet serves as a vital component in the ongoing management of non-small cell lung cancer.
Benefits
Gefitinib Tablet 250 mg inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Iressa Tablet may help to slow the progression of cancer.
Iressa 250 mg may help reduce the severity of cancer-related symptoms, such as pain and fatigue, which can improve a patient's overall quality of life.
Gefitinib Tablet 250 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.
Side Effects
As with all medicines, Iressa 250 mg Strip may cause some side effects. If you experience any of these side effects, you should contact your doctor or health care professional as soon as possible. Your doctor may be able to suggest ways in which these side effects can be managed or the severity of them reduced.
Most Common Side Effects
• Tremor
• Hypertension
• Headache
• Increased Potassium levels in the blood
• Hypertension
• Gastrointestinal problems
• Abnormal Growth of Hair
Common Side Effects
• Liver Damage
• Seizures
• Infection
• Kidney Damage
• Memory Problems
• Vision Problems
• Sleeplessness
How To Use
It is recommended to consume Iressa 250 mg Strip with or without food. Be sure to swallow the tablet whole with a complete glass of water. Avoid crushing, chewing, or opening the tablet. In case you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and adhere to your regular dosing schedule. Remember not to take two doses simultaneously to compensate for a missed dose.
Safety Advice
• Alcohol: The use of alcohol is generally not recommended while taking Anti-cancer Drug Iressa as it may increase the risk of liver damage. It is advisable to either abstain from alcohol or limit your alcohol intake while taking any medication.
• Kidney: Iressa 250 mg Tablet is considered safe for patients with mild to moderate kidney disease and no dose adjustment of Iressa 250 mg is required. However, people with severe kidney disease are advised not to take Iressa Tablet Tablet. To ensure the safety and effectiveness of your treatment, it is important to have an open discussion with your doctor about all your medical conditions and medications.
• Breastfeeding: It is not advisable to breast-feed while taking Iressa Tablet as this may cause harm to the baby. Iressa 250 mg Tablet can pass into breast milk and cause adverse effects. If you are currently breastfeeding and using Gefitinib Tablet 250 mg, it is important to discuss with your doctor the potential risks and benefits of continuing to breastfeed. Your doctor will help you make the decision that is best for you and your baby.
• Liver: Iressa 250 mg Tablet is considered safe for patients with mild to moderate liver disease, and there is no need to adjust the dose of Gefitinib Tablet 250 mg. However, people with severe liver disease should not use Anti-cancer Drug Iressa. It is important to have an open discussion with your doctor about your medical conditions and medications to ensure that the treatment plan is appropriate for you.
• Pregnancy: Iressa 250 mg Tablet may be unsafe during pregnancy as animal studies suggest that it may harm the developing fetus. However, if you are pregnant or planning to get pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Iressa 250 mg Strip while pregnant. Your doctor will be able to help you make the decision that is best for you and for the health of your baby.
• Driving: Iressa 250 mg Tablet may cause dizziness, drowsiness, and problems with concentration and coordination, which may impair your ability to drive a vehicle safely. It is important that you follow your doctor's instructions and take the necessary measures, such as avoiding driving or operating heavy machinery, if you experience any of these side effects caused by Gefitinib Tablet 250 mg.